1. Home
  2. INOD vs TRVI Comparison

INOD vs TRVI Comparison

Compare INOD & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innodata Inc.

INOD

Innodata Inc.

N/A

Current Price

$35.49

Market Cap

2.4B

Sector

Technology

ML Signal

N/A

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

N/A

Current Price

$13.72

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INOD
TRVI
Founded
1988
2011
Country
United States
United States
Employees
3000
34
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
1.9B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
INOD
TRVI
Price
$35.49
$13.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
★ $111.50
$28.18
AVG Volume (30 Days)
★ 1.8M
1.6M
Earning Date
11-05-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
3.37
★ 31.91
EPS
★ 1.13
N/A
Revenue
★ $86,775,000.00
N/A
Revenue This Year
$42.87
N/A
Revenue Next Year
$27.95
N/A
P/E Ratio
$32.14
★ N/A
Revenue Growth
★ 9.84
N/A
52 Week Low
$34.23
$9.82
52 Week High
$125.14
$20.22

Technical Indicators

Market Signals
Indicator
INOD
TRVI
Relative Strength Index (RSI) 32.21 48.85
Support Level $34.37 $13.00
Resistance Level $47.79 $14.75
Average True Range (ATR) 3.52 0.92
MACD -0.62 0.13
Stochastic Oscillator 7.62 39.87

Price Performance

Historical Comparison
INOD
TRVI

About INOD Innodata Inc.

Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: